Last reviewed · How we verify

Clindamycin + Gentamicin — Competitive Intelligence Brief

Clindamycin + Gentamicin (Clindamycin + Gentamicin) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antibiotic combination (lincosamide + aminoglycoside). Area: Infectious Disease.

marketed Antibiotic combination (lincosamide + aminoglycoside) Bacterial ribosome (50S subunit for clindamycin; 30S subunit for gentamicin) Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Clindamycin + Gentamicin (Clindamycin + Gentamicin) — Mercy Health Ohio. Clindamycin and gentamicin are a combination antibiotic therapy that inhibits bacterial protein synthesis through different mechanisms to provide broad-spectrum coverage against aerobic and anaerobic pathogens.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Clindamycin + Gentamicin TARGET Clindamycin + Gentamicin Mercy Health Ohio marketed Antibiotic combination (lincosamide + aminoglycoside) Bacterial ribosome (50S subunit for clindamycin; 30S subunit for gentamicin)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antibiotic combination (lincosamide + aminoglycoside) class)

  1. Mercy Health Ohio · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Clindamycin + Gentamicin — Competitive Intelligence Brief. https://druglandscape.com/ci/clindamycin-gentamicin. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: